| Bioactivity | N1-Methyl-3’-O-(2-methoxyethyl) adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | N1-Methyl-3’-O-(2-methoxyethyl) adenosine |
| Formula | C14H21N5O5 |
| Molar Mass | 339.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
N1-Methyl-3’-O-(2-methoxyethyl) adenosine
CAS: F: C14H21N5O5 W: 339.35
N1-Methyl-3’-O-(2-methoxyethyl) adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.